398 related articles for article (PubMed ID: 16267249)
1. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
Leaf A; Albert CM; Josephson M; Steinhaus D; Kluger J; Kang JX; Cox B; Zhang H; Schoenfeld D;
Circulation; 2005 Nov; 112(18):2762-8. PubMed ID: 16267249
[TBL] [Abstract][Full Text] [Related]
2. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.
Raitt MH; Connor WE; Morris C; Kron J; Halperin B; Chugh SS; McClelland J; Cook J; MacMurdy K; Swenson R; Connor SL; Gerhard G; Kraemer DF; Oseran D; Marchant C; Calhoun D; Shnider R; McAnulty J
JAMA; 2005 Jun; 293(23):2884-91. PubMed ID: 15956633
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
4. The role of fish oil in arrhythmia prevention.
Anand RG; Alkadri M; Lavie CJ; Milani RV
J Cardiopulm Rehabil Prev; 2008; 28(2):92-8. PubMed ID: 18360184
[TBL] [Abstract][Full Text] [Related]
5. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.
Brouwer IA; Zock PL; Camm AJ; Böcker D; Hauer RN; Wever EF; Dullemeijer C; Ronden JE; Katan MB; Lubinski A; Buschler H; Schouten EG;
JAMA; 2006 Jun; 295(22):2613-9. PubMed ID: 16772624
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of coronary artery disease with omega-3 fatty acids.
Jacobson TA
Am J Cardiol; 2006 Aug; 98(4A):61i-70i. PubMed ID: 16919518
[TBL] [Abstract][Full Text] [Related]
7. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
Christensen JH
Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
Stuber T; Eigenmann C; Delacrétaz E
Pacing Clin Electrophysiol; 2005 Jul; 28(7):702-7. PubMed ID: 16008807
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy.
Metcalf RG; Sanders P; James MJ; Cleland LG; Young GD
Am J Cardiol; 2008 Mar; 101(6):758-61. PubMed ID: 18328835
[TBL] [Abstract][Full Text] [Related]
10. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
[TBL] [Abstract][Full Text] [Related]
12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
13. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators.
Christensen JH; Riahi S; Schmidt EB; Mølgaard H; Kirstein Pedersen A; Heath F; Cosedis Nielsen J; Toft E
Europace; 2005 Jul; 7(4):338-44. PubMed ID: 15944091
[TBL] [Abstract][Full Text] [Related]
14. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
[TBL] [Abstract][Full Text] [Related]
15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
16. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
Leaf A
J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S27-9. PubMed ID: 17876194
[TBL] [Abstract][Full Text] [Related]
17. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
18. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial.
Singer P; Wirth M
Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):153-9. PubMed ID: 15253884
[TBL] [Abstract][Full Text] [Related]
19. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
Wilkoff BL; Ousdigian KT; Sterns LD; Wang ZJ; Wilson RD; Morgan JM;
J Am Coll Cardiol; 2006 Jul; 48(2):330-9. PubMed ID: 16843184
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure.
Wilhelm M; Tobias R; Asskali F; Kraehner R; Kuly S; Klinghammer L; Boehles H; Daniel WG
Am Heart J; 2008 Jun; 155(6):971-7. PubMed ID: 18513506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
